Yan J, Jin Y, Lo E, Chen Y, Hanlon Newell AE, Kong Y, Inge L
Biomarker testing is increasingly crucial for patients with early-stage non-small cell lung cancer (eNSCLC). This exploratory study aimed to understand biomarker test utilization over time in eNSCLC patients in the real-world setting.